These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hemodynamic effects of guanfacine in essential hypertension. Feldstein CA, Cohen AA, Sabaris RP, Burucúa JE. Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009 [Abstract] [Full Text] [Related]
3. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)]. Rosenthal J, Schäfer N, Rauh J, Raschig A. Dtsch Med Wochenschr; 1980 Nov 28; 105(48):1680-4. PubMed ID: 7002524 [Abstract] [Full Text] [Related]
4. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)]. Rosenthal J, Jäger H. MMW Munch Med Wochenschr; 1980 Jan 25; 122(4):137-40. PubMed ID: 6767938 [Abstract] [Full Text] [Related]
5. [Clinical pharmacology of the antihypertensive action of guanfacine]. Safar M, Weiss Y, Georges D. Arch Mal Coeur Vaiss; 1980 Oct 25; 73(10):1171-7. PubMed ID: 6778409 [Abstract] [Full Text] [Related]
6. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension. Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S. Clin Ther; 1985 Oct 25; 7(2):199-204. PubMed ID: 3886142 [Abstract] [Full Text] [Related]
7. Long-term efficacy and tolerance of the antihypertensive agent guanfacine. Jerie P, Lasance A. Int J Clin Pharmacol Ther Toxicol; 1984 Mar 25; 22(3):170-4. PubMed ID: 6370876 [Abstract] [Full Text] [Related]
8. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy. Jerie P, Lasance A. Int J Clin Pharmacol Ther Toxicol; 1981 Jun 25; 19(6):279-87. PubMed ID: 7030975 [Abstract] [Full Text] [Related]
10. Long-term clinical experience with guanfacine. Fetkovská N, Brimichová G, Sebeková K, Dzúrik R. Cor Vasa; 1987 Jun 25; 29(4 Suppl 1):23-9. PubMed ID: 3315447 [Abstract] [Full Text] [Related]
11. [A new antihypertensive agent used in a clinical setting]. Wetzels E, Raschig A, Kaiser HJ. Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207 [Abstract] [Full Text] [Related]
12. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa. Malini PL, Strocchi E, Ambrosioni E, Magnani B. Int J Clin Pharmacol Res; 1983 Sep 12; 3(1):35-9. PubMed ID: 6384071 [Abstract] [Full Text] [Related]
14. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)]. Magometschnigg D, Bonelli J, Hitzenberger G, Kaik G. Arzneimittelforschung; 1980 Sep 12; 30(6):1005-7. PubMed ID: 6998487 [Abstract] [Full Text] [Related]
15. [Efficacy of guanfacine in the treatment of arterial hypertension]. de Broucker D, Graux P, Dutoit A, Croccel L. LARC Med; 1982 Sep 12; 2(7):613-5. PubMed ID: 6762476 [No Abstract] [Full Text] [Related]
17. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension]. Kravchenko IG, Liashenko MM, Tarnakin AG, Chirkov SN. Kardiologiia; 1986 Mar 12; 26(3):41-5. PubMed ID: 3520085 [Abstract] [Full Text] [Related]
18. [Effect of long-term treatment with guanfacine on selected humoral metabolic indices in patients with primary hypertension]. Knypl K, Wocial B, Chodakowska J, Brym E, Czerniewska E, Wacławek-Maczkowska J, Kuczyńska K, Berent H, Januszewicz W. Pol Tyg Lek; 1986 Mar 12; 44(12-13):293-6. PubMed ID: 2530502 [Abstract] [Full Text] [Related]